Mersana Therapeutics, Inc. (MRSN)
Q4 2019 Results Conference Call
February 28, 2020 08:00 AM ET
Company Participants
Sarah Carmody - Executive Director, IR and Corporate Communications
Anna Protopapas - CEO
Brian DeSchuytner - SVP, Finance and Product Strategy
Conference Call Participants
Jonathan Chang - SVB Leerink
Boris Peaker - Cowen
Debjit Chattopadhyay - H.C. Wainwright
Jessica Fye - JP Morgan
Mike Ulz - Baird
David Nierengarten - Wedbush Securities
Presentation
Operator
Good morning, and welcome to Mersana Therapeutics Fourth Quarter and Year-End 2019 Conference Call. Currently, all participants are in listen-only mode. There will be